Skip Ribbon Commands
Skip to main content
Navigate Up

Advanced Issues in Opioid Dependence Treatment

This course is held under the auspices of the Office of Continuing Professional Development, Faculty of Medicine, University of Toronto and Centre for Addiction and Mental Health in Toronto, Ontario.



This interactive workshop provides physicians, pharmacists, nurses and counsellors with the knowledge and skills to manage special issues related to people receiving opioid agonist treatment.  The course is a part of the Opioid Dependence Treatment Certificate Program.

The Advanced Issues in opioid dependence treatment course covers a range of topics addressing the complexity of opioid dependence treatment.  The workshop is offered once per year, and each year the topics covered in the workshop are based on needs assessment survey conducted prior to the workshop.

Learning objectives:

  • Describe an approach to management of opioid use disorders in pregnancy.
  • Review benefits and risks of opioid agonist treatment during pregnancy: methadone, buprenorphine and buprenorphine/naloxone.
  • Describe pregnancy-specific recommendations for the use of methadone and buprenorphine including induction, maintenance and dose adjustments.
  • Review best practice recommendations for management of the opioid-exposed infant.
  • Compare and contrast the effectiveness, adverse effects and safety of buprenorphine-naloxone versus methadone in the treatment for or opioid use disorders
  • Outline an evidence-based approach to choosing buprenorphine or methadone as the initial medicaiton, considering the following factors: Patient's health status, pattern of drug use (eg. injection versus oral use), and social situation (work and family obligations)
  • Describe "office induction" and "home induction" protocols for starting patients on buprenorphine
  • State the clinical criteria for switching from buprenorphine to methadone, and vice versa
  • Describe how to avoid precipitated withdrawal when transferring patients from methadone to buprenorphine
  • Discuss the factors to consider in prescribing take-home doses of buprenorphine
  • Develop an approach to discussing opioid overdose and naloxone with  patients on methadone or buprenorphine
  • Prepare for managing suspected opioid overdose events in your clinic  setting


Target Audience

Pharmacists, physicians, counsellors/case managers and nurses

Delivery Method

Classroom workshop - Case studies exploration and discussion


Participants must have completed the Opioid Dependence Treatment Core course, or have an experience of at least one year providing methadone maintenance treatment.


The continuing education event indicated has been designated as a U of T Accredited event and awarded with the following credits:

Royal College of Physicians & Surgeons of Canada - __Section 1 credits;

The College of Family Physicians of Canada- __Certified Group Learning credits



Participants who are not pursing the Certificate have the option of taking elective courses independently.


For the overall course description, learning objectives, delivery method, target audience and information about the ODT certificate please visit the Main Page for the ODT Certificate below:



University of Toronto


November 26, 2016 (Saturday, following the Methadone prescribers' conference)

8:00 am - 1:00 pm

Centre for Addiction and Mental Health
33 Russell St, Room 2029
Toronto, Ontario

Fee: $225

Please click on the link below to register:


Robyn Steidman

Education Assistant

416-535-8501 x36640

CAMH Switchboard 416-535-8501
CAMH General Information Toronto: 416-595-6111 Toll Free: 1-800-463-6273
Connex Ontario Help Lines
Queen St.
1001 Queen St. W
Toronto, ON
M6J 1H4
Russell St.
33 Russell St.
Toronto, ON
M5S 2S1
College St.
250 College St.
Toronto, ON
M5T 1R8
Ten offices across Ontario